Comments

ImmunoPrecise Antibodies

IPANASDAQ
Logo brought to you by Benzinga Data
PerksBuyCompare Brokers
PerksBuyCompare Brokers
$0.670000
-0.0050-0.74%
At Close: -
$0.697100
0.034.04%
After Hours: 4:09 PM EDT
15 minutes delayed
Q1 2025 Earnings were released on Mon Sep 16th, before the market open
The most recent conference call was at 10:30 AM, 4 days ago Click to view past webcast
ImmunoPrecise Antibodies (IPA) ForecastNewsEarnings

Guidance

DividendsAnalyst RatingsInsider TradesShort Interest

ImmunoPrecise Antibodies (NASDAQ:IPA) Stock, Guidance And Forecast

Companies issue guidance, or expectations of future EPS and revenue, so investors have a sense of how much money a company will make in a future period.

Data brought to you by Benzinga APIs

FAQ

Q

What is the most recent guidance for ImmunoPrecise Antibodies (IPA)?

A

There have been no specific sales or earnings guidance reported for ImmunoPrecise Antibodies in recent months.

Browse guidance and forecast on all stocks.